Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Food and Drug Administration Safety Over Sequestration Act of 2015
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2015 (HR 1078); FDA, NIH, and BARDA/CDC appropriations.
Food and Drug Administration Safety Over Sequestration Act of 2015
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2015 (HR 1078); FDA, NIH, and BARDA/CDC appropriations.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
STRONG Patents Act of 2015 (S632); The Innovation Act (HR9)
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2015 (HR 1078); FDA, NIH, and BARDA/CDC appropriations.
Source: Senate LDA
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2015 (S/141 HR 1190)Medicare Access and Children's Health Insurance Plans Re-Authorization Act of 2015 (HR2)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2015 (S/141 HR 1190)Medicare Access and Children's Health Insurance Plans Re-Authorization Act of 2015 (HR2)
340B Drug Pricing Program; Critical Care; 21st Century Cures initiative; Medical Device Tax Repeal (HR160/S149); Innovation for Healthier Americans Initiative
340B Drug Pricing Program; Critical Care; 21st Century Cures initiative; Medical Device Tax Repeal (HR160/S149); Innovation for Healthier Americans Initiative
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2015 (S/141 HR 1190)Medicare Access and Children's Health Insurance Plans Re-Authorization Act of 2015 (HR2)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2015 (S/141 HR 1190)Medicare Access and Children's Health Insurance Plans Re-Authorization Act of 2015 (HR2)
STRONG Patents Act of 2015 (S632); The Innovation Act (HR9)
STRONG Patents Act of 2015 (S632); The Innovation Act (HR9)
340B Drug Pricing Program; Critical Care; 21st Century Cures initiative; Medical Device Tax Repeal (HR160/S149); Innovation for Healthier Americans Initiative
340B Drug Pricing Program; Critical Care; 21st Century Cures initiative; Medical Device Tax Repeal (HR160/S149); Innovation for Healthier Americans Initiative
STRONG Patents Act of 2015 (S632); The Innovation Act (HR9)
STRONG Patents Act of 2015 (S632); The Innovation Act (HR9)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2013 (HR 2651).
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2013 (HR 2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2014 (S 2966/HR2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2013 (HR 2651); 21st Century Cures initiative
Food and Drug Administration Safety Over Sequestration Act of 2013
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
Food and Drug Administration Safety Over Sequestration Act of 2013
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
Food and Drug Administration Safety Over Sequestration Act of 2013
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
Food and Drug Administration Safety Over Sequestration Act of 2013
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2014 (S 2966/HR2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2013 (HR 2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2013 (HR 2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2014 (S 2966/HR2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2014 (S 2966/HR2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
Pharmaceutical pedigree anti-counterfeiting proposals (S959 and HR 1919)
Pharmaceutical pedigree anti-counterfeiting proposals (S959/HR 1919)
Pharmaceutical pedigree anti-counterfeiting proposals (S959/HR 1919)
340B Drug Pricing Program; Critical Care; Critical Care Assessment and Improvement Act of 2013 (HR 2651).
340B Drug Pricing Program; Critical Care; Critical Care Assessment and Improvement Act of 2013 (HR 2651).
Food and Drug Administration Safety Over Sequestration Act of 2013
Deficit reduction/impact of sequestration on FDA and NIH; Food and Drug Administration Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
Food and Drug Administration Safety Over Sequestration Act of 2013
Deficit reduction/impact of sequestration on FDA and NIH; Food and Drug Administration Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
340B Drug Pricing Program; Critical Care; Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (HR 307)
Pandemic and All-Hazards Preparedness Reauthorization Act of 2013
340B Drug Pricing Program; Critical Care; Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (HR 307)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Deficit reduction/impact of sequestration on FDA and NIH; Food and Drug Administration Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
Deficit reduction/impact of sequestration on FDA and NIH; Food and Drug Administration Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Pharmaceutical pedigree anti-counterfeiting proposals (S959/HR 1919)
Pharmaceutical pedigree anti-counterfeiting proposals (S959 and HR 1919)
Pharmaceutical pedigree anti-counterfeiting proposals (S959/HR 1919)
HR2227 Medical Gas Safety Act; HR 971 Critical Care Assessment and Improvement Act of 2011; HR5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation; HR 3590 The Patient Protection and Affordable Care Act
H.R.2227 - Medical Gas Safety Act; H.R.971 - Critical Assessment and Improvement Act of 2011; H.R.5651 - Food and Drug Administration Reform Act of 2012; S.3187 - Food and Drug Administration Safety and Innovation; and The Patient Protection and Afforable Care Act
HR2227 Medical Gas Safety Act; HR 971 Critical Care Assessment and Improvement Act of 2011; HR5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation; HR 3590 The Patient Protection and Affordable Care Act
H.R.2227 - Medical Gas Safety Act; H.R.971 - Critical Assessment and Improvement Act of 2011; H.R.5651 - Food and Drug Administration Reform Act of 2012; S.3187 - Food and Drug Administration Safety and Innovation; and The Patient Protection and Afforable Care Act
HR2227 Medical Gas Safety Act; HR 971 Critical Care Assessment and Improvement Act of 2011; HR5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation; HR 3590 The Patient Protection and Affordable Care Act
HR2227 Medical Gas Safety Act; HR 971 Critical Care Assessment and Improvement Act of 2011; HR5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation; HR 3590 The Patient Protection and Affordable Care Act
H.R.2227 - Medical Gas Safety Act; H.R.971 - Critical Assessment and Improvement Act of 2011; H.R.5651 - Food and Drug Administration Reform Act of 2012; S.3187 - Food and Drug Administration Safety and Innovation; and The Patient Protection and Afforable Care Act
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2015 (S/141 HR 1190)Medicare Access and Children's Health Insurance Plans Re-Authorization Act of 2015 (HR2)
340B Drug Pricing Program; Critical Care; 21st Century Cures initiative; Medical Device Tax Repeal (HR160/S149); Innovation for Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
STRONG Patents Act of 2015 (S632); The Innovation Act (HR9)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2015 (S/141 HR 1190)Medicare Access and Children's Health Insurance Plans Re-Authorization Act of 2015 (HR2)
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2015 (HR 1078); FDA, NIH, and BARDA/CDC appropriations.
340B Drug Pricing Program; Critical Care; 21st Century Cures initiative; Medical Device Tax Repeal (HR160/S149); Innovation for Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
Funding for rare disease research
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2014 (S 2966/HR2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
Funding for rare disease research
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2013 (HR 2651); 21st Century Cures initiative; Medical Device Tax Repeal (HR 523/S232)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413); FDA and BARDA/CDC appropriations.
Funding for rare disease research
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2013 (HR 2651); 21st Century Cures initiative
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
340B Drug Pricing Program; Critical Care Assessment and Improvement Act of 2013 (HR 2651).
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 1316 and HR 351)
Funding for rare disease research
Pharmaceutical pedigree anti-counterfeiting proposals (S959/HR 1919)
Funding for rare disease research
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Funding for rare disease research
Deficit reduction/impact of sequestration on FDA and NIH; Food and Drug Administration Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
340B Drug Pricing Program; Critical Care; Critical Care Assessment and Improvement Act of 2013 (HR 2651).
Pharmaceutical pedigree anti-counterfeiting proposals (S959 and HR 1919)
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Funding for rare disease research
Pharmaceutical pedigree anti-counterfeiting proposals
340B Drug Pricing Program; Critical Care; Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (HR 307)
Funding for rare disease research
HR2227 Medical Gas Safety Act; HR 971 Critical Care Assessment and Improvement Act of 2011; HR5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation; HR 3590 The Patient Protection and Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2227 - Medical Gas Safety Act; H.R.971 - Critical Assessment and Improvement Act of 2011; H.R.5651 - Food and Drug Administration Reform Act of 2012; S.3187 - Food and Drug Administration Safety and Innovation; and The Patient Protection and Afforable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
The Patient Protection and Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Deficit reduction/impact of sequestration on FDA and NIH; FDA Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
340B Drug Pricing Program; Critical Care; Critical Care Assessment and Improvement Act of 2013 (HR 2651).
Deficit reduction/impact of sequestration on FDA and NIH; Food and Drug Administration Safety Over Sequestration Act of 2013 (HR 2725); FDA User Fee Protection Act (S 1413)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Pharmaceutical pedigree anti-counterfeiting proposals (S959/HR 1919)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Deficit reduction/impact of sequestration on FDA and NIH
340B Drug Pricing Program; Critical Care; Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (HR 307)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Non-interference; rebates; Protecting Seniors' Access to Medicare Act of 2013 (S 351 and HR 351)
Deficit reduction/impact of sequestration on FDA and NIH
Filing targets: HOUSE OF REPRESENTATIVES, SENATE